Zydus Lifesciences Ltd 2024 SR
The report highlights Zydus Lifesciences' ESG performance for FY 2023-24, focusing on its Indian operations. Key achievements include a 13% reduction in GHG intensity and a 16% reduction in water intensity compared to the previous year. The company committed to carbon neutrality for Scope 1 and 2 emissions by 2035 and achieved 29% renewable energy usage. Socially, it maintained zero fatalities for two consecutive years and expanded healthcare access through the Zydus Medical College and Hospital. Governance was strengthened with 27.27% board gender diversity and 64% board independence.
Company: Zydus Lifesciences Ltd
Sector: Health Care
Country: India
Year: 2024
Type: SR
Pages: 91
Zydus Lifesciences Ltd
ESG Report
The report highlights Zydus Lifesciences' ESG performance for FY 2023-24, focusing on its Indian operations. Key achievements include a 13% reduction in GHG intensity and a 16% reduction in water intensity compared to the previous year. The company committed to carbon neutrality for Scope 1 and 2 emissions by 2035 and achieved 29% renewable energy usage. Socially, it maintained zero fatalities for two consecutive years and expanded healthcare access through the Zydus Medical College and Hospital. Governance was strengthened with 27.27% board gender diversity and 64% board independence.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target